Kidney-Pancreas Transplants: Is It So Difficult to Start a Program?
| Autor: | C. Fernández, P. Villaverde, Javon Oliver, R. Garcı́a, M. Gómez, J. Aguirrezabalaga, F Valdés, Arancha Alonso |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Adult
Graft Rejection Male Reoperation medicine.medical_specialty Time Factors medicine.medical_treatment Urinary system Urology Postoperative Complications Prednisone Laparotomy medicine Humans Diabetic Nephropathies Immunosuppression Therapy Hematoma Transplantation Type 1 diabetes C-Peptide Thymoglobulin business.industry Graft Survival Immunosuppression medicine.disease Kidney Transplantation Surgery Diabetes Mellitus Type 1 Hemoglobin A Cytomegalovirus Infections Kidney Failure Chronic Female Pancreas Transplantation business Follow-Up Studies medicine.drug |
| Zdroj: | Transplantation Proceedings. 37:1455-1456 |
| ISSN: | 0041-1345 |
| Popis: | Background For selected patients with type 1 diabetes mellitus and end-stage renal failure, simultaneous kidney-pancreas (SKP) or pancreas after kidney (PAK) transplantation is the treatment of choice. However, it is frequently difficult to start a program for fear of serious intraabdominal complications in an immunosuppressed patient. We review our initial experience with these transplantations. Methods Twenty-three patients (20 SKP, 3 PAK) with type 1 diabetes mellitus received transplants between June 2000 and October 2003. All received immunosuppression therapy with thymoglobulin, prednisone, tacrolimus, and mycophenolate mofetil. The operation included portal venous drainage and exocrine enteric drainage. Rejections were biopsy-proved. Cytomegalovirus prophylaxis with gancyclovir was administered. Results The mean follow-up is 13 months (range, 1–30 months) for recipients of mean age 39 ± 7 years (17 men, 6 women). Mean cold ischemia time for kidney was 10.2 ± 3.9 hours, and for pancreas was 10.5 ± 3 hours. The rate of initial graft function was 100%. Graft rejection rate was 8%. The repeat laparotomy rate was 53% (12 patients), with a mean of 0.8 procedures per patient (range, 0 to 5). At the end of follow-up, patient survival was 95%, kidney survival was 85%, and pancreas survival was 83%. Patients with a functioning graft were insulin-free, with a mean fasting glucose concentration of 79 ± 7 mg/dL, hemoglobin A 1C of 4.5% (range, 4% to 4.9%) C-peptide of 5.9 ng/mL (range, 2.1 to 12 ng/mL), and a mean serum creatinine level of 1.6 mg/dL (range, 0.9 to 4.6 mg/dL). There was 1 death, due to posttransplantation lymphoproliferative disease confined to the pancreatic graft and abdominal sepsis at 3 months posttransplantation. Conclusions Our results are similar to those of other series of SPK or PAK transplantations: low acute rejection rates, frequent requirement for repeat laparotomy, and good patient and graft survival, permitting an excellent quality of life. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect